FDA-Inspected Site

Haemonetics Software Solutions

2 FDA inspections are on record for Haemonetics Software Solutions in Rosemont, United States.

483· Form 483 issued

Rosemont, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2009-03-13.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Mar 2009Not recorded483View 483 →
16 Aug 2000Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

13 Mar 2009
21 CFR 820.22

Quality Audit/Reaudit - conducted

Cited by Laurie A Haxel, Karen E Masley-Joseph

13 Mar 2009
21 CFR 820.30(d)

Design output procedures

Cited by Laurie A Haxel, Karen E Masley-Joseph

13 Mar 2009
21 CFR 820.40(b)

Document change records, maintained.

Cited by Laurie A Haxel, Karen E Masley-Joseph

13 Mar 2009
21 CFR 820.100(a)(1)

Procedure for analysis of data sources

Cited by Laurie A Haxel, Karen E Masley-Joseph

13 Mar 2009
21 CFR 820.100(a)(2)

Investigation procedures

Cited by Laurie A Haxel, Karen E Masley-Joseph

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.30(d)Cited across public-safe Form 483 observations1x
21 CFR 820.40(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Haemonetics Software Solutions' 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat